# Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol

> **NCT00325767** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 10 (—)

## Conditions studied

- Mucociliary Clearance

## Interventions

- **DRUG:** nebulized albuterol (2.5 mg/3ml/dose)
- **DRUG:** nebulized levalbuterol (1.25 mg/3ml/dose)
- **DRUG:** nebulized placebo (3ml/dose)

## Key facts

- **NCT ID:** NCT00325767
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 10 (—)
- **Last updated:** 2006-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00325767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00325767, "Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00325767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*